Getting your Trinity Audio player ready...
|
“We have shown that distinct components of these blood vessels termed tight junctions are altered in Alzheimer’s disease. We think that this alteration could be an entrained mechanism to allow for the clearance of toxic amyloid-beta from the brain in those living with Alzheimer’s disease”
The research showed that these amyloid beta molecules could alter the barrier itself at zones called ‘tight junctions’. These are essentially tightly packed cells that act as a checkpoint, limiting what enters and leaves the brain. Amyloid beta seemed to trigger an opening of these junctions, in an attempt to clear it into the bloodstream. This previously unknown feature is by no means a ‘cure’, but clearance of amyloid beta is one treatment scientist’s hope could really combat the disease. In combination with other medicines, controlling the barrier and shepherding more amyloid beta through into the bloodstream, could turn out to be a potent solution. Read more at MedicalxpressCopyright © Gowing Life Limited, 2024 • All rights reserved • Registered in England & Wales No. 11774353 • Registered office: Ivy Business Centre, Crown Street, Manchester, M35 9BG.